Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells - PubMed (original) (raw)
Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells
Natalie Blaszczyk et al. Clin Cancer Res. 2004.
Abstract
Purpose: Prostate cancer metastasizes to the skeleton to form osteoblastic lesions. Androgen ablation is the current treatment for metastatic prostate cancer. This therapy is palliative, and the disease will return in an androgen-independent form that is preceded by a rising titer of prostate-specific antigen (PSA). Here, we investigated the possibility that human osteoblasts might secrete factors that contribute to the emergence of androgen-independent prostate cancer.
Experimental design: Primary cultures of human osteoblasts were used as a source of conditioned medium (OCM). Proliferation, expression of androgen-regulated genes, and transactivation of the androgen receptor (AR) were monitored in LNCaP human prostate cancer cells in response to OCM using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Northern blot analysis, and reporter gene constructs. Levels of interleukin-6 (IL-6) present in OCM were measured, and its contribution to proliferation and expression of PSA were investigated by neutralization studies with anti IL-6 antibodies.
Results: OCM increased the proliferation and expression of PSA at both the protein and RNA levels in LNCaP cells. Synergistic increases in the activities of PSA (6.1 kb)- and pARR(3)-tk-luciferase reporters were measured in cells cotreated with both OCM and androgen. OCM targeted the NH(2)-terminal domain of the AR. The effect of OCM on transcriptional activity of the AR was inhibited by an antiandrogen. Neutralizing antibodies to IL-6 blocked proliferation and expression of PSA by OCM.
Conclusion: Osteoblasts secrete factors, such as IL-6, that cause androgen-independent induction of PSA gene expression and proliferation of prostate cancer cells by a mechanism that partially relies on the AR. Identifying such molecular mechanisms may lead to improved clinical management of metastatic prostate cancer.
Similar articles
- Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.
Lu Y, Zhang J, Dai J, Dehne LA, Mizokami A, Yao Z, Keller ET. Lu Y, et al. Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6. Clin Exp Metastasis. 2004. PMID: 15672864 - Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT. Denmeade SR, et al. Prostate. 2003 Mar 1;54(4):249-57. doi: 10.1002/pros.10199. Prostate. 2003. PMID: 12539223 - [Research on the structure of the PSA promoter and the mechanisms of its expression regulation].
Wang J, Zhou JG, Huang CF. Wang J, et al. Yi Chuan. 2004 Sep;26(5):739-44. Yi Chuan. 2004. PMID: 15640095 Review. Chinese. - Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
Culig Z, Bartsch G, Hobisch A. Culig Z, et al. Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. doi: 10.1016/s0303-7207(02)00263-0. Mol Cell Endocrinol. 2002. PMID: 12431817 Review.
Cited by
- Luteolin inhibits A549 cells proliferation and migration by down-regulating androgen receptors.
Li X, Tang Y, Liang P, Sun M, Li T, Shen Z, Sha S. Li X, et al. Eur J Med Res. 2023 Sep 16;28(1):353. doi: 10.1186/s40001-023-01302-4. Eur J Med Res. 2023. PMID: 37716981 Free PMC article. - Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation.
Iuliani M, Simonetti S, Ribelli G, Cavaliere S, Vincenzi B, Tonini G, Pantano F, Santini D. Iuliani M, et al. Biomedicines. 2022 Sep 1;10(9):2154. doi: 10.3390/biomedicines10092154. Biomedicines. 2022. PMID: 36140255 Free PMC article. - Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms.
Ribelli G, Simonetti S, Iuliani M, Rossi E, Vincenzi B, Tonini G, Pantano F, Santini D. Ribelli G, et al. Front Oncol. 2021 Dec 13;11:789885. doi: 10.3389/fonc.2021.789885. eCollection 2021. Front Oncol. 2021. PMID: 34966687 Free PMC article. - In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer.
Bock N, Kryza T, Shokoohmand A, Röhl J, Ravichandran A, Wille ML, Nelson CC, Hutmacher DW, Clements JA. Bock N, et al. Sci Adv. 2021 Jun 30;7(27):eabg2564. doi: 10.1126/sciadv.abg2564. Print 2021 Jun. Sci Adv. 2021. PMID: 34193425 Free PMC article. - Osteoblasts Generate Testosterone From DHEA and Activate Androgen Signaling in Prostate Cancer Cells.
Moon HH, Clines KL, O'Day PJ, Al-Barghouthi BM, Farber EA, Farber CR, Auchus RJ, Clines GA. Moon HH, et al. J Bone Miner Res. 2021 Aug;36(8):1566-1579. doi: 10.1002/jbmr.4313. Epub 2021 May 18. J Bone Miner Res. 2021. PMID: 33900658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous